We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.10 | 0.27% | 36.85 | 36.85 | 37.10 | 37.05 | 36.25 | 36.40 | 449,522 | 16:35:08 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 217.94 | 200.13M |
TIDMAPH
RNS Number : 7735R
Alliance Pharma PLC
18 June 2018
TR-1: Standard form for notification of major holdings
Hot Features
Premium
1a. Identity of the issuer Alliance Pharma PLC
or the underlying issuer
of existing shares to which
voting rights are attached:
---------------------------------------------- ------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
------------------------------------------------------------------------------------------------
Non-UK issuer
--------------------------------------------------------------------------------- -------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
--------------------------------------------------------------------------------- -------------
An acquisition or disposal of financial instruments X
--------------------------------------------------------------------------------- -------------
An event changing the breakdown of voting rights
--------------------------------------------------------------------------------- -------------
Other (please specify):
--------------------------------------------------------------------------------- -------------
3. Details of person subject to the notification obligation
Name BlackRock, Inc.
City and country of registered Wilmington, DE, USA
office (if applicable)
4. Full name of shareholder(s) (if different from 3.)
------------------------------------------------------------------------------------------------
Name
---------------------------------------------- ------------------------------------------------
City and country of registered
office (if applicable)
---------------------------------------------- ------------------------------------------------
5. Date on which the threshold 14/06/2018
was crossed or reached:
---------------------------------------------- ------------------------------------------------
6. Date on which issuer notified 15/06/2018
(DD/MM/YYYY):
---------------------------------------------- ------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer
8. A) (total of
8.B 1 + 8.B
2)
-------------------- ------------------------ ---------------- --------------- -------------
Resulting
situation
on the date
on which
threshold
was crossed
or reached 4.98% 0.03% 5.02% 476,842,884
-------------------- ------------------------ ---------------- --------------- -------------
Position N/A N/A N/A
of previous
notification
(if
applicable)
-------------------- ------------------------ ---------------- --------------- -------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached
----------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
----------------------------------------------------------------------------------------------------------
Class/type Number of voting rights % of voting rights
of
shares
ISIN code
(if possible)
---------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10 of
Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
-------------------- ------------------------ -------------- ------------------------- --------------
GB0031030819 23,792,316 4.98%
--------------------- ------------------------ -------------- ------------------------- --------------
SUBTOTAL
8. A 23,792,316 4.98%
--------------------- ---------------------------------------- -----------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
----------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion rights that rights
Period(xi) may be acquired
if the instrument
is
exercised/converted.
--------------------- ------------------------ -------------- ------------------------- --------------
Securities
Lending 110,000 0.02%
--------------------- ------------------------ -------------- ------------------------- --------------
SUBTOTAL 8.
B 1 110,000 0.02%
-------------- ------------------------- --------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
----------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date Conversion or cash of voting rights
instrument Period settlement rights
-------------------- ------------------------- -------------- ------------ ----------- --------------
CFD Cash 39,519 0.00%
--------------------- ------------------------ -------------- ------------ ----------- --------------
SUBTOTAL
8.B.2 39,519 0.00%
------------ ----------- --------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer
Full chain of controlled undertakings through which X
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity (please add additional rows as necessary)
-------------------------------------------------------------- ---------------------
Name % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
---------------- ----------------- ----------------------- -----------------------
See Attachment
---------------- ----------------- ----------------------- -----------------------
10. In case of proxy voting, please identify:
-------------------------------------------------------------------------------------
Name of the proxy holder
----------------------------------- ------------------------------------------------
The number and % of voting
rights held
----------------------------------- ------------------------------------------------
The date until which the
voting rights will be held
----------------------------------- ------------------------------------------------
11. Additional information
-------------------------------------------------------------------------------------
BlackRock Regulatory Threshold Reporting Team
James Michael
020 7743 3650
-------------------------------------------------------------------------------------
Place of completion 12 Throgmorton Avenue, London, EC2N 2DL,
U.K.
-------------------- -----------------------------------------
Date of completion 15 June, 2018
-------------------- -----------------------------------------
Section 9 Attachment
Name(xv) % of voting % of voting Total of
rights if rights through both if
it equals financial it equals
or is higher instruments or is higher
than the notifiable if it equals than the
threshold or is higher notifiable
than the notifiable threshold
threshold
------------------------- --------------------- --------------------- --------------
BlackRock, Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Holdco 2,
Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Financial
Management, Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Holdco 4,
LLC
------------------------- --------------------- --------------------- --------------
BlackRock Holdco 6,
LLC
------------------------- --------------------- --------------------- --------------
BlackRock Delaware
Holdings Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Fund Advisors
------------------------- --------------------- --------------------- --------------
BlackRock, Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Holdco 2,
Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Financial
Management, Inc.
------------------------- --------------------- --------------------- --------------
BlackRock International
Holdings, Inc.
------------------------- --------------------- --------------------- --------------
BR Jersey International
Holdings L.P.
------------------------- --------------------- --------------------- --------------
BlackRock Group Limited
------------------------- --------------------- --------------------- --------------
BlackRock Investment
Management (UK) Limited
------------------------- --------------------- --------------------- --------------
BlackRock, Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Holdco 2,
Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Financial
Management, Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Holdco 4,
LLC
------------------------- --------------------- --------------------- --------------
BlackRock Holdco 6,
LLC
------------------------- --------------------- --------------------- --------------
BlackRock Delaware
Holdings Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Fund Advisors
------------------------- --------------------- --------------------- --------------
BlackRock Institutional
Trust Company, National
Association
------------------------- --------------------- --------------------- --------------
BlackRock, Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Holdco 2,
Inc.
------------------------- --------------------- --------------------- --------------
BlackRock Financial
Management, Inc.
------------------------- --------------------- --------------------- --------------
BlackRock International
Holdings, Inc.
------------------------- --------------------- --------------------- --------------
BR Jersey International
Holdings L.P.
------------------------- --------------------- --------------------- --------------
BlackRock Group Limited
------------------------- --------------------- --------------------- --------------
BlackRock Advisors
(UK) Limited
------------------------- --------------------- --------------------- --------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLEAKKPFFDPEFF
(END) Dow Jones Newswires
June 18, 2018 12:17 ET (16:17 GMT)
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
